Advanced Glycation End Product-Induced Astrocytic Differentiation Of Cultured Neurospheres Through Inhibition Of Notch-Hes1 Pathway-Mediated Neurogenesis

Yijing Guo,Pin Wang,Haixia Sun,Rongrong Cai,Wenqing Xia,Shaohua Wang
DOI: https://doi.org/10.3390/ijms15010159
IF: 5.6
2014-01-01
International Journal of Molecular Sciences
Abstract:This study aims to investigate the roles of the Notch-Hes1 pathway in the advanced glycation end product (AGE)-mediated differentiation of neural stem cells (NSCs). We prepared pLentiLox3.7 lentiviral vectors that express short hairpin RNA (shRNA) against Notch1 and transfected it into NSCs. Cell differentiation was analyzed under confocal laser-scanning microscopy. The percentage of neurons and astrocytes was quantified by normalizing the total number of TUJ1(+) (Neuron-specific class III beta-tubulin) and GFAP(+) (Glial fibrillary acidic protein) cells to the total number of Hoechst 33342-labeled cell nuclei. The protein and gene expression of Notch-Hes1 pathway components was examined via western blot analysis and real-time PCR. After 1 week of incubation, we found that AGE-bovine serum albumin (BSA) (400 mu g/mL) induced the astrocytic differentiation of cultured neurospheres and inhibited neuronal formation. The expression of Notch-Hes1 pathway components was upregulated in the cells in the AGE-BSA culture medium. Immunoblot analysis indicated that shRNA silencing of Notch1 expression in NSCs significantly increases neurogenesis and suppresses astrocytic differentiation in NSCs incubated with AGE-BSA. AGEs promote the astrocytic differentiation of cultured neurospheres by inhibiting neurogenesis through the Notch-Hes1 pathway, providing a potential therapeutic target for hyperglycemia-related cognitive deficits.
What problem does this paper attempt to address?